Ophthalmic drug delivery device

Details Ophthalmic drug delivery device Ophthalmic drug delivery device

2006-01-17

2006-01-17

Azpuru, Carlos A. (Department: 1615)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Implant or insert

Reexamination Certificate

active

06986900

ABSTRACT:
An ophthalmic drug delivery device having a scleral surface, an orbital surface, an injection port on the orbital surface, and a fluid conducting passageway disposed within the device that is fluidily coupled to the injection port and terminates in an opening for communicating the fluid to an outer surface of the sclera is disclosed. The fluid contains a pharmaceutically active agent useful for the treatment of a disease of the posterior segment of the eye.

REFERENCES:
patent: 3416530 (1968-12-01), Ness
patent: 3828777 (1974-08-01), Ness
patent: 4014335 (1977-03-01), Arnold
patent: 4300557 (1981-11-01), Refojo et al.
patent: 4327725 (1982-05-01), Cortese et al.
patent: 4624848 (1986-11-01), Lee
patent: 4853224 (1989-08-01), Wong
patent: 4946450 (1990-08-01), Erwin
patent: 4997652 (1991-03-01), Wong
patent: 5147647 (1992-09-01), Darougar
patent: 5164188 (1992-11-01), Wong
patent: 5178635 (1993-01-01), Gwon et al.
patent: 5300114 (1994-04-01), Gwon et al.
patent: 5322691 (1994-06-01), Darougar et al.
patent: 5378475 (1995-01-01), Smith et al.
patent: 5403901 (1995-04-01), Namdaran et al.
patent: 5443505 (1995-08-01), Wong et al.
patent: 5466233 (1995-11-01), Weiner et al.
patent: 5466466 (1995-11-01), Muller
patent: 5476511 (1995-12-01), Gwon et al.
patent: 5516522 (1996-05-01), Peyman et al.
patent: 5632984 (1997-05-01), Wong et al.
patent: 5679666 (1997-10-01), Clark
patent: 5710165 (1998-01-01), Kapin et al.
patent: 5725493 (1998-03-01), Avery et al.
patent: 5743274 (1998-04-01), Peyman
patent: 5766242 (1998-06-01), Wong et al.
patent: 5766619 (1998-06-01), Aiache et al.
patent: 5770592 (1998-06-01), Clark
patent: 5773019 (1998-06-01), Ashton et al.
patent: 5797898 (1998-08-01), Santini, Jr. et al.
patent: 5824072 (1998-10-01), Wong
patent: 5824073 (1998-10-01), Peyman
patent: 5830173 (1998-11-01), Avery et al.
patent: 5836935 (1998-11-01), Ashton et al.
patent: 5902598 (1999-05-01), Chen et al.
patent: 5904144 (1999-05-01), Hammang et al.
patent: 5916584 (1999-06-01), O'Donoghue
patent: 6001386 (1999-12-01), Ashton et al.
patent: 6074661 (2000-06-01), Olejnik et al.
patent: 6110485 (2000-08-01), Olejnik et al.
patent: 6120460 (2000-09-01), Abreu
patent: 6126687 (2000-10-01), Peyman
patent: 6146366 (2000-11-01), Schachar
patent: 6217895 (2001-04-01), Guo et al.
patent: 6375972 (2002-04-01), Guo et al.
patent: 6378526 (2002-04-01), Bowman et al.
patent: 6397849 (2002-06-01), Bowman et al.
patent: 6413245 (2002-07-01), Yaacobi et al.
patent: 6413540 (2002-07-01), Yaacobi
patent: 6416777 (2002-07-01), Yaacobi
patent: 6669950 (2003-12-01), Yaacobi
patent: 6713081 (2004-03-01), Robinson et al.
patent: 6719750 (2004-04-01), Varner et al.
patent: 2002/0188282 (2002-12-01), Greenberg
patent: 2003/0175324 (2003-09-01), Robinson et al.
patent: 2004/0180075 (2004-09-01), Robinson et al.
patent: 2004/0219181 (2004-11-01), Viscasillas
patent: 40 22 553 (1992-01-01), None
patent: 0 904 787 (1999-03-01), None
patent: 2149615 (2000-05-01), None
patent: WO 94/05257 (1994-03-01), None
patent: WO 95/26734 (1995-10-01), None
patent: WO 95/28984 (1995-11-01), None
patent: WO 96/36377 (1996-11-01), None
patent: WO 97/14415 (1997-04-01), None
patent: WO 98/23228 (1998-06-01), None
patent: WO 98/43611 (1998-10-01), None
patent: WO 99/07418 (1999-02-01), None
patent: WO 99/11244 (1999-03-01), None
patent: WO 99/32104 (1999-07-01), None
patent: WO 99/45920 (1999-09-01), None
patent: WO 00/56340 (2000-03-01), None
patent: WO 00/37066 (2000-06-01), None
patent: WO 01/49226 (2001-07-01), None
patent: WO 02/100318 (2002-02-01), None
“Bausch & Lomb and Control Delivery Systems Agree to Develop Breakthrough Therapeutic Products for Severe Eye Diseases;” Business Wire Via First!; NewsEdge Corp.; Jun. 15, 1999; 4 pp.
“Method of Placing Irrigation System into Tenon's Space,” E.I. Sidorenko, et al., Abstract of Russian Patent No. RU 2123314, issued Dec. 20, 1998, 1 pg.
“A New method for Posterior Sub-Tenon's Drug Administration,” NESTEROV, et al., Ophthalmic Surgery, vol. 24, No. 1, Jan. 1993, pp. 59-61.
DIALOG File 266:FEDRIP database record; Identifying No. 122098; “Implantation of a Sub-Tenon Drug Delivery Device Loaded with a Test Article in Rabbits and Distribution of the Test Article in Ocular Tissues;” Compiled and distributed by NTIS; 1 page; Jun. 3, 1999.
DIALOG File 266: FEDRIP database record; Identifying No. 134284; “Implantation of a Sub-Tenon Drug Delivery Device Loaded with a Test Article in Rabbits and Distribution of the Test Article in Ocular Tissues;” Complied and distributed by NTIS; 1 page.
DIALOG File 266: FEDRIP database record; Identifying No. 131476; Ocular Bioavailability of AL-3789 and AL-4940 after Sub-Tenon's Injection of AL-3789 Ophthalmic Suspensions in New Zealand White Rabbits; Complied and distributed by NTIS; 1 page.

Affiliated with

Also associated with

Rating

Ophthalmic drug delivery device does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmic drug delivery device, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic drug delivery device will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3562340